Stocks · Korea 048870 KOSDAQ

Synergy Innovation

1,605원 +0.69% Market cap 1,414억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 7 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER45.86x

PBR0.67x

EPS35 KRW

BPS2,401 KRW

ROE5.19%

Dividend yield0.00%

DPS0 KRW

Payout ratio0.00%

Returns and 52-week range

1W+0.37%

1M+1.89%

3M-5.56%

6M-25.58%

1Y-41.27%

YTD-31.42%

52W high2,770원

52W low1,385원

From 52W high-41.70%

Financial results (consolidated)

Period	Revenue	Operating income	Net income	OP margin
2021	810억	134억	97억	16.6%
2022	303억	12억	228억	4.0%
2023	832억	150억	75억	18.0%
2025	1,131억	192억	112억	16.9%
Quarterly
2024 3Q	242억	41억	-79억	16.8%
2025 1Q	272억	48억	26억	17.6%
2025 2Q	277억	47억	34억	16.9%
2025 3Q	304억	64억	62억	21.0%
2025 4Q	278억	33억	-10억	11.9%
2026 1Q	270억	38억	56억	14.1%

Company

CEO박진형

Founded1998-04-02

Fiscal year end12

Websitewww.synergyinnovation.co.kr

Address: 경기도 성남시 중원구 사기막골로 52 5층(상대원동, 선텍시티2)

Peers in the same sector

Company	Market cap	P/E	P/B	1M
메쥬	1,476억	35.40	12.46	-42.05%
레이언스	1,372억	—	0.55	+16.81%
엘앤케이바이오	1,515억	—	3.25	+76.68%
동방메디컬	1,336억	11.15	1.08	+10.26%
엠아이텍	1,526억	7.51	1.21	-8.27%
디오	1,328억	—	0.69	-10.08%

Recent filings

2026-09-30[기재정정]주요사항보고서(타법인주식및출자증권양도결정) Major
2026-09-09[기재정정]주요사항보고서(타법인주식및출자증권양도결정) Major
2026-08-14반기보고서 (2026.06)
2026-08-04[기재정정]주요사항보고서(타법인주식및출자증권양도결정) Major
2026-07-29[기재정정]주요사항보고서(타법인주식및출자증권양도결정) Major
2026-06-30[기재정정]주요사항보고서(타법인주식및출자증권양도결정) Major
2026-06-15[기재정정]주요사항보고서(타법인주식및출자증권양도결정) Major
2026-05-15분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.